Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.
Company address
Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, 500034
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Natco Pharma Ltd or scroll over to Natco Pharma Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Natco Pharma Ltd?
The share price of Natco Pharma Ltd stocks is ₹1,332.45 as on 27/07/2024
What is the Market Cap of Natco Pharma Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Natco Pharma Ltd stock is ₹23,865.5 Cr on 27/07/2024.
In which sector / industry does Natco Pharma Ltd operate?
Natco Pharma Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.
What was the revenue of Natco Pharma Ltd?
The revenue of Natco Pharma Ltd as of 2023 was ₹3,998.8 Cr
What is the PE ratio of Natco Pharma Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Natco Pharma Ltd is
17.23 as on 27/07/2024.
What is the 52 week high price of Natco Pharma Ltd?
The 52 week high of Natco Pharma Ltd stock is ₹1,349.00.
What is the 52 week low price of Natco Pharma Ltd?
The 52 week low of Natco Pharma Ltd stock is ₹725.00.
Can fractional shares of Natco Pharma Ltd be purchased?
No, you cannot buy fractional shares of Natco Pharma Ltd, or any listed Indian company as of now.